Olanzapine/samidorphan will decrease the level or impact of hydromorphone by pharmacodynamic antagonism. Contraindicated. Samidorphan elicits opioid antagonistic effects and raises risk of precipitating acute opioid withdrawal in patients dependent on opioids. The usage of DILAUDID INJECTION is not encouraged for clients using MAOIs or in 14 days of stopping this https://robertx456nmk6.blogproducer.com/profile